JP2022528487A5 - - Google Patents
Info
- Publication number
- JP2022528487A5 JP2022528487A5 JP2021557938A JP2021557938A JP2022528487A5 JP 2022528487 A5 JP2022528487 A5 JP 2022528487A5 JP 2021557938 A JP2021557938 A JP 2021557938A JP 2021557938 A JP2021557938 A JP 2021557938A JP 2022528487 A5 JP2022528487 A5 JP 2022528487A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotides
- dsrna
- rna
- oligonucleotide
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962826589P | 2019-03-29 | 2019-03-29 | |
| US62/826,589 | 2019-03-29 | ||
| US201962864789P | 2019-06-21 | 2019-06-21 | |
| US62/864,789 | 2019-06-21 | ||
| US201962910842P | 2019-10-04 | 2019-10-04 | |
| US62/910,842 | 2019-10-04 | ||
| PCT/US2020/025432 WO2020205605A2 (en) | 2019-03-29 | 2020-03-27 | OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022528487A JP2022528487A (ja) | 2022-06-13 |
| JP2022528487A5 true JP2022528487A5 (enExample) | 2023-04-03 |
Family
ID=72667058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557938A Pending JP2022528487A (ja) | 2019-03-29 | 2020-03-27 | Ｃ９ｏｒｆ７２のオリゴヌクレオチドベースの調節 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20200385737A1 (enExample) |
| EP (1) | EP3946374A4 (enExample) |
| JP (1) | JP2022528487A (enExample) |
| AU (1) | AU2020252020A1 (enExample) |
| CA (1) | CA3133784A1 (enExample) |
| WO (1) | WO2020205605A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160319278A1 (en) | 2015-04-03 | 2016-11-03 | University Of Massachusetts | Fully stabilized asymmetric sirna |
| WO2017030973A1 (en) | 2015-08-14 | 2017-02-23 | University Of Massachusetts | Bioactive conjugates for oligonucleotide delivery |
| JP7406793B2 (ja) | 2017-06-23 | 2023-12-28 | ユニバーシティー オブ マサチューセッツ | ２テイル自己デリバリー型ｓｉＲＮＡおよび関連方法 |
| US11279930B2 (en) | 2018-08-23 | 2022-03-22 | University Of Massachusetts | O-methyl rich fully stabilized oligonucleotides |
| US11629347B2 (en) | 2019-05-06 | 2023-04-18 | University Of Massachusetts | Anti-C9ORF72 oligonucleotides and related methods |
| KR20220047989A (ko) | 2019-08-09 | 2022-04-19 | 유니버시티 오브 매사추세츠 | Snp를 표적화하는 화학적으로 변형된 올리고뉴클레오타이드 |
| WO2021041247A1 (en) * | 2019-08-23 | 2021-03-04 | University Of Massachusetts | O-methyl rich fully stabilized oligonucleotides |
| US12365894B2 (en) | 2019-09-16 | 2025-07-22 | University Of Massachusetts | Branched lipid conjugates of siRNA for specific tissue delivery |
| WO2021195510A1 (en) | 2020-03-27 | 2021-09-30 | University Of Massachusetts | Dual-acting sirna based modulation of c9orf72 |
| WO2021242883A1 (en) | 2020-05-26 | 2021-12-02 | University Of Massachusetts | Synthetic oligonucleotides having regions of block and cluster modifications |
| US20240200063A1 (en) * | 2021-03-24 | 2024-06-20 | Atalanta Therapeutics, Inc. | Microglial gene silencing using double-stranded sirna |
| WO2022204430A1 (en) * | 2021-03-24 | 2022-09-29 | Atalanta Therapeutics, Inc. | Double-stranded sirna having patterned chemical modifications |
| EP4347822A2 (en) * | 2021-06-04 | 2024-04-10 | Alnylam Pharmaceuticals, Inc. | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof |
| EP4430191A2 (en) * | 2021-11-08 | 2024-09-18 | University Of Massachusetts | Oligonucleotides for sod1 modulation |
| WO2023133550A2 (en) * | 2022-01-10 | 2023-07-13 | University Of Massachusetts | Oligonucleotides for mecp2 modulation |
| EP4569116A2 (en) * | 2022-08-09 | 2025-06-18 | The University of Massachusetts | Identification of allele-specific target sequences for c9orf72 |
| US20250145992A1 (en) * | 2023-10-18 | 2025-05-08 | University Of Massachusetts | Oligonucleotides with ethylene glycol modification |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090176725A1 (en) * | 2005-08-17 | 2009-07-09 | Sirna Therapeutics Inc. | Chemically modified short interfering nucleic acid molecules that mediate rna interference |
| RU2615143C2 (ru) * | 2010-03-24 | 2017-04-04 | Адвирна | Самодоставляющие PHKi соединения уменьшенного размера |
| CN104968783B (zh) * | 2012-10-15 | 2019-12-10 | Ionis制药公司 | 用于调节c9orf72表达的组合物 |
| US10221414B2 (en) * | 2013-10-11 | 2019-03-05 | Ionis Pharmaceuticals, Inc. | Compositions for modulating C9ORF72 expression |
| IL316808A (en) * | 2014-08-20 | 2025-01-01 | Alnylam Pharmaceuticals Inc | Modified double-stranded RNA materials and their uses |
| US20160319278A1 (en) * | 2015-04-03 | 2016-11-03 | University Of Massachusetts | Fully stabilized asymmetric sirna |
| RS60230B1 (sr) * | 2015-04-16 | 2020-06-30 | Ionis Pharmaceuticals Inc | Kompozicije za moduliranje ekspresije c9orf72 |
| WO2016201301A1 (en) * | 2015-06-12 | 2016-12-15 | Alnylam Pharmaceuticals, Inc. | Complement component c5 irna compositions and methods of use thereof |
| KR20180118111A (ko) * | 2015-12-23 | 2018-10-30 | 크리스퍼 테라퓨틱스 아게 | 근위축성 측색 경화증 및/또는 전두측두엽 퇴행의 치료 물질 및 방법 |
| US10478503B2 (en) * | 2016-01-31 | 2019-11-19 | University Of Massachusetts | Branched oligonucleotides |
| SG11201906728TA (en) * | 2017-02-06 | 2019-08-27 | Mpeg La Llc | Multimeric oligonucleotides having decreased kidney clearance |
| JP2020522510A (ja) * | 2017-06-02 | 2020-07-30 | ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． | オリゴヌクレオチド組成物及びその使用方法 |
| JP7406793B2 (ja) * | 2017-06-23 | 2023-12-28 | ユニバーシティー オブ マサチューセッツ | ２テイル自己デリバリー型ｓｉＲＮＡおよび関連方法 |
| US10905707B2 (en) * | 2017-11-10 | 2021-02-02 | University Of Massachusetts | Compositions and methods for the treatment of expanded repeat-associated disorders |
| KR20220115995A (ko) * | 2019-12-13 | 2022-08-19 | 알닐람 파마슈티칼스 인코포레이티드 | 인간 염색체 ９ 개방 판독 프레임 72 (C9orf72) iRNA 제제 조성물 및 이의 사용 방법 |
-
2020
- 2020-03-27 JP JP2021557938A patent/JP2022528487A/ja active Pending
- 2020-03-27 EP EP20782396.4A patent/EP3946374A4/en active Pending
- 2020-03-27 US US16/833,107 patent/US20200385737A1/en active Pending
- 2020-03-27 WO PCT/US2020/025432 patent/WO2020205605A2/en not_active Ceased
- 2020-03-27 AU AU2020252020A patent/AU2020252020A1/en active Pending
- 2020-03-27 CA CA3133784A patent/CA3133784A1/en active Pending
-
2023
- 2023-06-09 US US18/332,415 patent/US20240132892A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022528487A5 (enExample) | ||
| JP2022525208A5 (enExample) | ||
| US10538763B2 (en) | Compounds and methods for modulation of DUX4 | |
| CN113164509B (zh) | 用于抑制17β-HSD 13型(HSD17B13)表达的RNAi试剂、其组合物和使用方法 | |
| JP6638923B2 (ja) | キメラ２重鎖核酸 | |
| JP2023522701A5 (enExample) | ||
| JP2021533804A5 (enExample) | ||
| JP2018516091A5 (enExample) | ||
| JP2021533762A5 (enExample) | ||
| CN115397436B (zh) | 用于抑制PNPLA3表达的RNAi剂、其药物组合物和使用方法 | |
| WO2018062510A1 (ja) | オーバーハングを有する二本鎖核酸複合体 | |
| CN105682687A (zh) | 异染色质形成性非编码rna | |
| JP2023518268A5 (enExample) | ||
| CA3020487A1 (en) | Treatment of idiopathic pulmonary fibrosis using rna complexes that target connective tissue growth factor | |
| KR20220069103A (ko) | 최소 플루오린 함량을 갖는 작은 간섭 rna의 화학적 변형 | |
| CN119768186A (zh) | 用于向cns组织递送治疗剂的脂质缀合物 | |
| JP6882735B2 (ja) | 構造強化されたｍｉＲＮＡ阻害剤Ｓ−ＴｕＤ | |
| JP2024528252A (ja) | 核酸医薬の徐放性能の強化方法 | |
| JP2025542580A (ja) | 遺伝子サイレンシング技術としての、デオキシリボヌクレオチドが散在している短鎖二重鎖ｒｎａ、およびその使用 | |
| JP2024535869A (ja) | Ｗｆｄｃ２の発現を調節するアンチセンス化合物 | |
| EP4446414A1 (en) | Antisense oligonucleotide complex | |
| Riasi et al. | Gene Silencing Method Based on DNA. | |
| HK40084771B (zh) | 用於抑制PNPLA3表达的RNAi剂、其药物组合物和使用方法 | |
| CN121127248A (zh) | 用于抑制线粒体偕胺肟还原组分1 (MARC1)表达的RNAi剂、其药用组合物及使用方法 | |
| WO2024254589A2 (en) | Products and compositions |